三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
2015-2023年我国特异性免疫球蛋白产品批签发批次情况
2015-2023年我国特异性免疫球蛋白产品批签发批次情况
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:205KB
图片尺寸:1966*738
同报告图片
/
4
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
fCDlubTku70gfCDph4fmtYbph4/vvIjlkKjvvIkgfCDph4fmtYbph495b3kgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgMjAxOCB8IDM1MCB8IC0gfAp8IDIwMTkgfCAzNzAgfCAtIHwKfCAyMDIwIHwgMzgwIHwgLSB8CnwgMjAyMSB8IDQyMCB8IC0gfAp8IDIwMjIgfCA0NTAgfCAtIHwKfCAyMDIzIHwgNDcwIHwgLSB8CnwgMjAyNEgxIHwgMjUwIHwgLSB8CgrotYTmlpnmnaXmupDvvJrljZrpm4XnlJ/nianlhazlj7jlhazlkYrvvIzlpKrlubPmtIvor4HliLjmlbTnkIY=
fCDlubTku70gfCDlnKjov5DokKXmtYbnq5kgfCDlnKjlu7rmtYbnq5kgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IDIwMTggfCAxMiAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMTkgfCAxMiAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjAgfCAxMyAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjEgfCAxNCAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjIgfCAxNCAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjMgfCAxNCAgICAgICAgIHwgMiAgICAgICAgfAp8IDIwMjRIMSB8IDE0ICAgICAgICAgfCAyICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrljZrpm4XnlJ/nianlhazlj7jlhazlkYrvvIzlpKrlubPmtIvor4HliLjmlbTnkIY=
所属报告:
生物医药Ⅱ行业深度研究:以血制品行业盈利模型窥其投资价值几何-241201(61页).pdf
打包全文图表
相关数据
图表20PFA具备较强的组织选择特异性
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
收藏
行业数据
2026-06-26
原图定位
查看详情
lgA肾病被定义为肾小球系膜区出现显性或共同显性lgA(Immunoglobulin A,免疫球蛋白A)沉积.
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
收藏
行业数据
2026-01-23
原图定位
查看详情
TRiM™能将RNAi特异性地递送到不同组织中,实现治疗不同类型疾病的目的
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
收藏
行业数据
2025-09-28
原图定位
查看详情
TRiM™能将RNAi特异性地递送到不同组织中,实现治疗不同类型疾病的目的
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
收藏
行业数据
2025-09-28
原图定位
查看详情
同类药物的器官特异性应答率,TQ05105应答率最优(非头对头)
fCDlmajlrpggICAgICAgfCBUUTA1MTA1ICAgICAgIHwgUnV4b2xpdGluaWIgfCBCZWx1bW9zdWRpbCB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLXwKfCDnmq7ogqQgICAgICAgfCA2NSUgKDE3LzI2KSAgIHwgNDElICAgICAgICAgfCAzNyUgICAgICAgICB8Cnwg55y8552bICAgICAgIHwgNTQlICgyMC8zNykgICB8IDI2JSAgICAgICAgIHwgNDIlICAgICAgICAgfAp8IOWYtOW3tCAgICAgICB8IDQ0JSAoMTUvMzQpICAgfCA1MCUgICAgICAgICB8IDU1JSAgICAgICAgIHwKfCDpo5/nrqEgICAgICAgfCA3OSUgKDE1LzE5KSAgIHwgNTAlICAgICAgICAgfCA0NSUgICAgICAgICB8Cnwg5LiK5raI5YyW6YGTICAgfCA0MCUgKDIvNSkgICAgIHwgNDAlICAgICAgICAgfCA1MiUgICAgICAgICB8Cnwg5LiL5raI5YyW6YGTICAgfCA5MSUgKDEwLzExKSAgIHwgNTMlICAgICAgICAgfCA2OSUgICAgICAgICB8Cnwg6IKd6ISPICAgICAgIHwgMTAwJSAoNS81KSAgICB8IDI0JSAgICAgICAgIHwgMzklICAgICAgICAgfAp8IOiCuiAgICAgICAgIHwgMjMlICg2LzI2KSAgICB8IDklICAgICAgICAgIHwgMjYlICAgICAgICAgfAp8IOWFs+iKgi/nrYvohpwgIHwgNjglICgxMy8xOSkgICB8IDM4JSAgICAgICAgIHwgNzElICAgICAgICAgfAoK5p2l5rqQ77yaMjAyNEFTSCwg44CKUnV4b2xpdGluaWIgZm9yIEdsdWNvY29ydGljb2lkIC0gUmVmcmFjdG9yeSBDaHJvbmljIEdyYWZ0IC0gdmVyc3VzIC0gSG9zdCBEaXNlYXNlLuOAiywg44CKQmVsdW1vc3VkaWw=
收藏
行业数据
2025-09-24
原图定位
查看详情
同类药物的器官特异性应答率,TQ05105应答率最优(非头对头)
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
收藏
行业数据
2025-09-24
原图定位
查看详情
表21、EGFR、c-Met多特异性抗体全球竞争格局(临床阶段)
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
收藏
竞争格局
2025-07-24
原图定位
查看详情
表4、B细胞血液瘤CD3多特异性抗体全球竞争格局
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
收藏
竞争格局
2025-07-24
原图定位
查看详情
图4、与PROTAC相关的具有组织分布特异性的E3连接酶
fCBFM+i/nuaOpemFtuexu+WeiyB8IEUz6L+e5o6l6YW256S65L6LIHwKfCAtLS0gfCAtLS0gfAp8IENOUy1lbnJpY2hlZCBFM3MgfCBUUklNOSwgUk5GMTgyLCBNYW55IG90aGVycyB8CnwgVHVtb3VyLWVucmljaGVkIEUzcyB8IERDQUYyLCBUUklNNzEsIE1BR0VzLCBNYW55IG90aGVycyB8CnwgTXVzY2xlLWVucmljaGVkIEUzcyB8IEtMSEw0MSwgS0xITDQwIHwKfCBVYmlxdWl0b3VzIEUzcyB8IENVTDRCLCBWSEwsIEdJRDQsIE1hbnkgb3RoZXJzIHwKCui1hOaWmeadpea6kO+8mkLDqWvDqXMgTSwgTGFuZ2xleSBEUiwgQ3Jld3MgQ00uIFBST1RBQyB0YXJnZXRlZCBwcm90ZWluIGRlZ3JhZGVyczogdGhl
收藏
行业数据
2025-05-23
原图定位
查看详情
SI-B001是一种靶向EGFR及HER3的四价双特异性抗体
fCDmipdFR0ZSIHwg5oqXSEVSMyB8IHd0IEZjIGxnRzEgfAp8LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfAp8IOe6ouiJsuaWueWdlyB8IOiTneiJsuaWueWdlyB8IOeBsOiJsuaWueWdlyAgICB8
收藏
行业数据
2025-04-14
原图定位
查看详情
611治疗特异性皮炎的EASI75及NRS优于度普利尤单抗(II期数据)
fCBDb21wYW55IHwgSW5kaWNhdGlvbiB8IENvZGUgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgQSB8IEFEIGFwcHJvdmVkIHwgIHwKfCBCIHwgQXN0aG1hIE5EQSByZXZpZXdpbmcgfCAgfAp8IDNTQmlvIHwgQXN0aG1hIFBoYXNlIElJIGNvbXBsZXRlZCB8ICB8CnwgIHwgQUQgUGhhc2UgSUlJIHwgIHwKfCAgfCBDUlN3TlAgUGhhc2UgSUlJIHwgIHwKfCAgfCBDT1BEIFBoYXNlIElJIHwgIHwKfCAgfCBTU0dKLTYxMSB8ICB8CgrotYTmlpnmnaXmupDvvJrkuInnlJ/liLboja/lhazlj7jlrpjnvZHvvIzlm73nm5vor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-03-24
原图定位
查看详情
多特异性抗体与单抗和双特异性抗体的比较
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
收藏
行业数据
2025-02-06
原图定位
查看详情
全球进入临床阶段的多特异性抗体梳理
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
收藏
行业数据
2025-02-06
原图定位
查看详情
2000-2020年全球免疫球蛋白消费量(公吨)
fCDlubTku70gfCDlhY3nlqvnkIPom4vnmb3mtojotLnph4/vvIjlhazlkKjvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMDAgfCA0Ny40ICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMDUgfCA2OC44ICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTAgfCAxMDcuMyAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTUgfCAxNjcuNiAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjAgfCAyNTMuMyAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaTVJC77yM5YWJ5aSn6K+B5Yi456CU56m25omA
收藏
行业数据
2024-12-16
原图定位
查看详情
CSL2012-2023财年免疫球蛋白销售情况,基本保持稳健增长
fCDlubTku70gfCDlhY3nlqvnkIPom4vnmb3okKXmlLbvvIjkur/nvo7lhYPvvIkgfCDlkIzmr5QgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgMjAxMiB8IDE3LjAgfCAtIHwKfCAyMDEzIHwgMjAuMCB8IC0gfAp8IDIwMTQgfCAyMi4wIHwgLSB8CnwgMjAxNSB8IDI1LjAgfCAtIHwKfCAyMDE2IHwgMjguMCB8IC0gfAp8IDIwMTcgfCAzMC4wIHwgLSB8CnwgMjAxOCB8IDMyLjAgfCAtIHwKfCAyMDE5IHwgMzUuMCB8IC0gfAp8IDIwMjAgfCA0MC4wIHwgLSB8CnwgMjAyMSB8IDQyLjAgfCAtIHwKfCAyMDIyIHwgNDUuMCB8IC0gfAp8IDIwMjMgfCA1MC4wIHwgLSB8CgrotYTmlpnmnaXmupDvvJpDU0zotKLmiqXvvIzlhYnlpKfor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2024-12-16
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
我国有 4 类特异性免疫球蛋白产品上市,分别为狂犬病人免疫球蛋白、破伤风人免疫球蛋白、乙型肝炎人免疫球蛋白和组织胺人免疫球蛋白。特免批签发批次总体保持上升趋势,2015-2023 年CAGR 为 8.45%,其中:(1)狂免和破免:是批签发占比较大的品种,2023 年分别占 37.50%和43.13%,2019-2023 年 CAGR 分别为-8.74%和 4.21%;(2)乙免:由于我国乙肝防治工作取得进展,其需求减少;(3)组织胺人免疫球蛋白:2021 起进入批签发,目前规模较小,2021-2023 年CAGR 为 123.63%。
行业数据
原图定位
当前图表所属:
生物医药Ⅱ行业深度研究:以血制品行业盈利模型窥其投资价值几何-241201(61页).pdf
2026年血制品行业深度报告:采浆量2025年破15000吨,四代静丙与出海前景
规模较小的血制品企业往往经营困难,为头部企业进行并购提供了可行性
2018-2024H1博雅生物采浆量及同比增速
2018-2024H1博雅生物在营浆站及在建浆
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》